BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $87,286 | -20.6% | 2,152 | -0.2% | 0.01% | -26.7% |
| Q4 2022 | $109,942 | -5.2% | 2,157 | +0.1% | 0.02% | -21.1% |
| Q3 2022 | $116,000 | -15.9% | 2,155 | +0.5% | 0.02% | -9.5% |
| Q2 2022 | $138,000 | -20.2% | 2,144 | -4.1% | 0.02% | -19.2% |
| Q1 2022 | $173,000 | -11.7% | 2,236 | -1.8% | 0.03% | -10.3% |
| Q4 2021 | $196,000 | -10.1% | 2,278 | -16.1% | 0.03% | -12.1% |
| Q3 2021 | $218,000 | +1.4% | 2,716 | +1.6% | 0.03% | -8.3% |
| Q2 2021 | $215,000 | -4.0% | 2,673 | +0.5% | 0.04% | -62.1% |
| Q1 2021 | $224,000 | +7.2% | 2,661 | +2.2% | 0.10% | +2.2% |
| Q4 2020 | $209,000 | -1.9% | 2,603 | -1.7% | 0.09% | +10.7% |
| Q3 2020 | $213,000 | -6.6% | 2,649 | 0.0% | 0.08% | -13.4% |
| Q2 2020 | $228,000 | +4.1% | 2,649 | -1.8% | 0.10% | -10.2% |
| Q1 2020 | $219,000 | -3.1% | 2,698 | -0.1% | 0.11% | +22.7% |
| Q4 2019 | $226,000 | +14.7% | 2,700 | +19.8% | 0.09% | +1.1% |
| Q3 2019 | $197,000 | +8.8% | 2,254 | +1.9% | 0.09% | +6.1% |
| Q2 2019 | $181,000 | +0.6% | 2,212 | -0.2% | 0.08% | +3.8% |
| Q1 2019 | $180,000 | +11.1% | 2,216 | -9.8% | 0.08% | +1.3% |
| Q4 2018 | $162,000 | -14.3% | 2,456 | +0.2% | 0.08% | -1.3% |
| Q3 2018 | $189,000 | +4.4% | 2,450 | 0.0% | 0.08% | -1.2% |
| Q2 2018 | $181,000 | +13.8% | 2,450 | 0.0% | 0.08% | +8.1% |
| Q1 2018 | $159,000 | -9.1% | 2,450 | -9.3% | 0.07% | -3.9% |
| Q4 2017 | $175,000 | +3.6% | 2,700 | 0.0% | 0.08% | -7.2% |
| Q3 2017 | $169,000 | +3.7% | 2,700 | 0.0% | 0.08% | 0.0% |
| Q2 2017 | $163,000 | +16.4% | 2,700 | 0.0% | 0.08% | +13.7% |
| Q1 2017 | $140,000 | +16.7% | 2,700 | 0.0% | 0.07% | +15.9% |
| Q4 2016 | $120,000 | -7.0% | 2,700 | 0.0% | 0.06% | -10.0% |
| Q3 2016 | $129,000 | +5.7% | 2,700 | 0.0% | 0.07% | +2.9% |
| Q2 2016 | $122,000 | +7.0% | 2,700 | -9.9% | 0.07% | +6.2% |
| Q4 2015 | $114,000 | +16.3% | 2,997 | 0.0% | 0.06% | +8.5% |
| Q3 2015 | $98,000 | -57.9% | 2,997 | -9.9% | 0.06% | -55.6% |
| Q2 2015 | $233,000 | +11.0% | 3,326 | +16.3% | 0.13% | +2.3% |
| Q4 2014 | $210,000 | +2.4% | 2,860 | 0.0% | 0.13% | +0.8% |
| Q3 2014 | $205,000 | -1.0% | 2,860 | 0.0% | 0.13% | +3.2% |
| Q2 2014 | $207,000 | -1.4% | 2,860 | 0.0% | 0.12% | -8.8% |
| Q1 2014 | $210,000 | -2.3% | 2,860 | -7.5% | 0.14% | +1.5% |
| Q4 2013 | $215,000 | +5.9% | 3,092 | 0.0% | 0.14% | -12.3% |
| Q3 2013 | $203,000 | -5.1% | 3,092 | 0.0% | 0.15% | -4.9% |
| Q2 2013 | $214,000 | -4.9% | 3,092 | 0.0% | 0.16% | -34.4% |
| Q1 2013 | $225,000 | +9.2% | 3,092 | 0.0% | 0.25% | -1.2% |
| Q4 2012 | $206,000 | – | 3,092 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |